DeFloria, a joint venture between Charlotte’s Web Holdings and Ajna BioSciences, is advancing toward the start of its Phase 2 clinical trial for AJA001, a cannabinoid-based (FDA) botanical drug developed to treat behavioral symptoms associated with autism spectrum disorder (ASD).
Cantourage [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”HIGH.F” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] German-based medical cannabis operator Cantourage has
Charlotte’s Web, the market leader in full spectrum cannabidiol (“CBD”) hemp extract wellness products, has named Jade Proudman, the Chief Executive Officer
RESULTS from a major US trial over 800 people over the past seven months found CBD use has zero impact
We won’t spam you
